Join
Live feed
·
INSIDERFilingvia Quantisnow
Kyntra Bio Inc. logo

Amendment: CEO Wettig Thane bought $19,852 worth of shares (2,800 units at $7.09), increasing direct ownership by 11% to 27,203 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KYNB· Kyntra Bio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KYNB (Kyntra Bio Inc.) and more on Quantisnow.